Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies
Pathological complete response (pCR) after neoadjuvant therapy is associated with favourable prognosis in oesophageal adenocarcinoma, but whether outcomes differ according to treatment modality remains uncertain. This study compared survival among pati...
Sam T. Alhayo, Kerry Chou, S. Markar et al.· Diseases of the esophagus· 0 citations
Technical errors during surgery are a major contributor to preventable adverse outcomes, driving demand for objective assessment tools. Laparoscopic cholecystectomy (LC) is a commonly performed procedure with a clearly defined set of procedure-related complications, making it an ideal candidate for targeted assessment....
E. Mainwaring, Nadia Guidozzi, Jonnie P. James et al.· Surgical Endoscopy· 0 citations
OBJECTIVE
To determine the impact of severity of esophageal anastomotic leak (AL), standardized by ECCG grading, on long-term survival within a contemporary multicenter cohort.
SUMMARY BACKGROUND DATA
Historical evidence suggesting AL is associated with increased recurrence and poor survival is limited by heterogeneo...
Lorenzo Giorgi, Nadia Guidozzi, Riadh Salem et al.· Annals of Surgery· 0 citations
Decision-making after ER for early OG cancer reflects a complex interplay of physical, psychological, and logistical priorities, which may fit poorly into current guidelines for early OG cancer therapy.
K. Cole, Pradeep Bhandari, Michael White et al.· Diseases of the esophagus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.